Lung Cancer
Volume 67, Issue 2 , Pages 227-231 , February 2010

Quantitative breath analysis of volatile organic compounds of lung cancer patients

  • Geng Song

      Affiliations

    • Department of Oncology, the First Affiliated Hospital of Anhui Medical University, 218 Ji-Xi Road, Hefei, China
    • ,
  • Tao Qin

      Affiliations

    • Department of Oncology, the First Affiliated Hospital of Anhui Medical University, 218 Ji-Xi Road, Hefei, China
    • ,
  • Hu Liu

      Affiliations

    • Department of Oncology, the First Affiliated Hospital of Anhui Medical University, 218 Ji-Xi Road, Hefei, China
    • Corresponding Author InformationCorresponding author. Tel.: +86 0551 2922354; fax: +86 0551 2922987.
    • ,
  • Guo-Bing Xu

      Affiliations

    • Anhui Institute for Drug Control, Hefei, China
    • ,
  • Yue-Yin Pan

      Affiliations

    • Department of Oncology, the First Affiliated Hospital of Anhui Medical University, 218 Ji-Xi Road, Hefei, China
    • ,
  • Fu-Xing Xiong

      Affiliations

    • Department of Oncology, the First Affiliated Hospital of Anhui Medical University, 218 Ji-Xi Road, Hefei, China
    • ,
  • Kang-Sheng Gu

      Affiliations

    • Department of Oncology, the First Affiliated Hospital of Anhui Medical University, 218 Ji-Xi Road, Hefei, China
    • ,
  • Guo-Ping Sun

      Affiliations

    • Department of Oncology, the First Affiliated Hospital of Anhui Medical University, 218 Ji-Xi Road, Hefei, China
    • ,
  • Zhen-Dong Chen

      Affiliations

    • Department of Oncology, the First Affiliated Hospital of Anhui Medical University, 218 Ji-Xi Road, Hefei, China

Received 1 October 2008 ,Revised 28 March 2009 ,Accepted 30 March 2009.

References 

  1. Wang QJ, Zhu WX, Xing XM, Li L. The trend of cancer incidence in urban Beijing from 1982 to 1997. China Oncol. 2001;10:507
  2. Yu M, Gong WW, Hu RY. An analysis of cancer mortality from 1990 to 2002 in Zhejiang Province. China Oncol. 2004;13:144–147
  3. Humphrey LL, Teutsch S, Johnson M. Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. preventive services task force. Ann Intern Med. 2004;140:740–753
  4. Callol L, Roig F, Cuevas A, de Granda JI, Villegas F, Jareno J, et al. Low-dose CT: a useful and accessible tool for the early diagnosis of lung cancer. Lung Cancer. 2006;56:217–221
  5. Hanibuchi M, Yano S, Nishioka Y, Miyoshi T, Kondo K, Uehara H, et al. Autofluorescence bronchoscopy, a novel modality for the early detection of bronchial premalignant and malignant lesions. J Med Invest. 2007;54:261–266
  6. Maldonado A, Gonzalez-Alenda FJ, Alonso M, Sierra JM. Usefulness of positron emission tomography-computed tomography in respiratory medicine. Arch Bronconeumol. 2007;43:562–572
  7. Pauling L, Robinson AB, Teranishi R, Cary P. Quantitative analysis of urine vapor and breath by gas–liquid partition chromatography. Proc Natl Acad Sci USA. 1971;68:2374–2376
  8. Kneepkens CM, Lepage G, Roy CC. The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Radic Biol Med. 1994;17:127–160
  9. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis. 2000;21:361–370
  10. Phillips M, Cataneo RN, Greenberg J, Grodman R, Gunawarddena R, Naidu A. Effect of oxygen on breath markers of oxidative stress. Eur Respir J. 2003;21:48–51
  11. Karin M. The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. Biol Chem. 1999;274:27339–27342
  12. Nair U, Bartsch H, Nair J. Lipid peroxidation-induced DNA damage in cancer-prone inflammatory diseases: a review of published adduct types and levels in humans. Free Radic Biol Med. 2007;43:1109–1120
  13. Hietanen E, Bartsch H, Bereziat JC, Camus AM, McClinton S, Eremin O, et al. Diet and oxidative stress in breast, colon and prostate cancer patients: a case-control study. Eur J Clin Nutr. 1994;48:575–586
  14. Gordon SM, Szidon JP, Krotoszynski BK, Gibbons RD, O’Neill HJ. Volatile organic compounds in exhaled air from patients with lung cancer. Clin Chem. 1985;31:1278–1282
  15. O’Neill HJ, Gordon SM, O’Neill MH, Gibbons RD, Szidon JP. A computerized classification technique for screening for the presence of breath biomarkers in lung cancer. Clin Chem. 1988;34:1613–1618
  16. Krotoszynski B, Gabriel G, O’Neil H. Characterization of human expired air: a promising investigative and diagnostic technique. J Chromatogr Sci. 1977;15:239–244
  17. Phillips M, Greenberg J. Ion-trap detection of volatile organic compounds in alveolar breath. Clin Chem. 1992;38:60–65
  18. Phillips M. Method for the collection and assay of volatile organic compounds in breath. Anal Biochem. 1996;247:272–278
  19. Phillips M, Gleeson K, Hughes JM, Greenberg J, Cataneo RN, Baker L, et al. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet. 1999;353:1930–1933
  20. Phillips M, Cataneo RN, Cummin AR, Gagliardi AJ, Gleeson K, Greenberg J, et al. Detection of lung cancer with volatile markers in the breath. Chest. 2003;123:2115–2123
  21. Potter DW, Pawliszyn J. Detection of substituted benzenes in water at the pg/ml level using solid-phase microextraction and gas chromatography-ion trap mass spectrometry. J Chromatogr. 1992;625:247–255
  22. Grote C, Pawliszyn J. Solid-phase microextraction for the analysis of human breath. Anal Chem. 1997;69:587–596
  23. Poli D, Carbognani P, Corradi M, Goldoni M, Acampa O, Balbi B, et al. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study. Respir Res. 2005;6:71
  24. London SJ, Daly AK, Fairbrother KS, Holmes C, Carpenter CL, Navidi WC, et al. Lung cancer risk in African-Americans in relation to a race-specific CYP1A1 polymorphism. Cancer Res. 1995;55:6035–6037
  25. Hu YL, Zhang Q. Genetic polymorphisms of CYP1A1 and susceptibility of lung cancer. Chin J Med Genet. 1999;1:26
  26. Paez JG, Janne PA, Lee JC, Tracy S, Greulich H, Gabriel S, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science. 2004;304:1497–1500
  27. Pan ZK, Zhang L, Zhang X, Wang X, Li N, Xu F, et al. Epidermal growth factor receptor mutation in Chinese patients with non-small cell lung cancer. Chin J Cancer. 2005;24:919–923
  28. Deng CH, Zhang XM, Li N. Investigation of volatile biomarkers in lung cancer blood using solid-phase microextraction and caplillary gas chromatography–mass spectrometry. J Chromatogr B. 2004;808:269–277
  29. McGarvey LJ, Shorten CV. The effects of adsorption on the reusability of Tedlar air sampling bags. AIHA J. 2000;61:375–380
  30. Steeghs MM, Cristescu SM, Harren FJ. The suitability of Tedlar bags for breath sampling in medical diagnostic research. Physiol Meas. 2007;28:73–84
  31. Tu RH, Mitchell CS, Kay GG, Risby TH. Human exposure to the jet fuel, JP-8. Aviat Space Environ Med. 2004;75:49–59
  32. Lirk P, Bodrogi F, Raifer H, Greiner K, Ulmer H, Rieder J. Elective haemodialysis increases exhaled isoprene. Nephrol Dial Transplant. 2003;18:937–941
  33. Anderson JC, Lamm WJ, Hlastala MP. Measuring airway exchange of endogenous acetone using a single-exhalation breathing maneuver. J Appl Physiol. 2006;100:880–889
  34. Hoffmann D, Brunnemann KD, Prokopczyk B, Djordjevic MV. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. J Toxicol Environ Health. 1994;41:1–52
  35. Schuller HM, Tithof PK, Williams M, Plummer H. The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a beta-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via beta-adrenergic receptor-mediated release of arachidonic acid. Cancer Res. 1999;59:4510–4515
  36. Wiseman H, Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J. 1996;313:17–29
  37. Brown NS, Bicknell R. Hypoxia and oxidative stress in breast cancer: oxidative stress—its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res. 2001;3:323–327

PII: S0169-5002(09)00208-6

doi: 10.1016/j.lungcan.2009.03.029

Lung Cancer
Volume 67, Issue 2 , Pages 227-231 , February 2010

Article Tools

* Image Usage & Resolution